ProPublica

Journalism in the Public Interest

Cancel

Prescriber Checkup

Prescriber Checkup » Missouri » Endocrinology, Diabetes Metabolism

Top Endocrinology, Diabetes Metabolism Prescribers in Missouri

Top Prescribers

Providers are grouped by the primary specialty they listed when applying for a national health ID number. This doesn’t necessarily mean the person has special training or certification. Specialty is self-reported by providers and may have changed. Patients and claims shown are for Medicare Part D only.

Prescriber Claims Filled Total Cost Medicare Part D Patients Claims for Brand Name Drugs Schedule Two Schedule Three Dangerous Drugs to Seniors Brand Name Drugs Prescription Price
CHUL KIM M.D.

Endocrinology, Diabetes Metabolism

26,965

$1.28M

371
181 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

48%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

23%
prescriptions for brand name drugs

Avg: 45%

$47
Average prescription price

Avg: $123

DANIEL LYONS MD

Endocrinology, Diabetes Metabolism

11,722

$1.32M

577
396 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 45%

$113
Average prescription price

Avg: $123

CHRISTOPHER CASE M.D.

Endocrinology, Diabetes Metabolism

10,647

$1.34M

630
416 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

6%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

43%
prescriptions for brand name drugs

Avg: 45%

$125
Average prescription price

Avg: $123

ALAN RAUBA M.D.

Endocrinology, Diabetes Metabolism

8,900

$1.03M

431
332 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 45%

$116
Average prescription price

Avg: $123

HOWARD ROSEN M.D.

Endocrinology, Diabetes Metabolism

8,832

$880K

552
408 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

38%
prescriptions for brand name drugs

Avg: 45%

$100
Average prescription price

Avg: $123

ROBERT SALTMAN MD

Endocrinology, Diabetes Metabolism

8,550

$825K

492
448 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

41%
prescriptions for brand name drugs

Avg: 45%

$97
Average prescription price

Avg: $123

JUNPING YANG MD

Endocrinology, Diabetes Metabolism

8,424

$1.13M

571
374 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 45%

$134
Average prescription price

Avg: $123

NORMAN FISHMAN M.D.

Endocrinology, Diabetes Metabolism

7,984

$918K

530
478 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

47%
prescriptions for brand name drugs

Avg: 45%

$115
Average prescription price

Avg: $123

KAREN PORTE M.D.

Endocrinology, Diabetes Metabolism

7,580

$502K

490
204 are 65+

2%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

27%
prescriptions for brand name drugs

Avg: 45%

$66
Average prescription price

Avg: $123

PETER BOYER M.D.

Endocrinology, Diabetes Metabolism

7,433

$474K

421
340 are 65+

6%
patients receiving schedule two controlled substances

Avg: 0%

11%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

22%
prescriptions for brand name drugs

Avg: 45%

$64
Average prescription price

Avg: $123

MATTHEW ORLAND MD

Endocrinology, Diabetes Metabolism

7,375

$551K

436
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

8%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

30%
prescriptions for brand name drugs

Avg: 45%

$75
Average prescription price

Avg: $123

MITCHELL HAMBURG M.D.

Endocrinology, Diabetes Metabolism

7,131

$1.01M

624
493 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 45%

$142
Average prescription price

Avg: $123

K. THAMPY M.D.

Endocrinology, Diabetes Metabolism

7,109

$1.71M

752
520 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

66%
prescriptions for brand name drugs

Avg: 45%

$241
Average prescription price

Avg: $123

WU WEN M.D.

Endocrinology, Diabetes Metabolism

6,671

$916K

480
280 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 45%

$137
Average prescription price

Avg: $123

GREGORY LEDGER MD

Endocrinology, Diabetes Metabolism

6,380

$735K

723
531 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 45%

$115
Average prescription price

Avg: $123

AMIN RADPARVAR M.D.

Endocrinology, Diabetes Metabolism

6,313

$586K

379
284 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

4%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

31%
prescriptions for brand name drugs

Avg: 45%

$93
Average prescription price

Avg: $123

JAMES BONUCCHI DO

Endocrinology, Diabetes Metabolism

6,295

$794K

416
245 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

3%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

51%
prescriptions for brand name drugs

Avg: 45%

$126
Average prescription price

Avg: $123

JEROME THURMAN M.D.,F.A.C.E.

Endocrinology, Diabetes Metabolism

6,233

$976K

682
498 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

52%
prescriptions for brand name drugs

Avg: 45%

$157
Average prescription price

Avg: $123

DANIEL GAITAN MD

Endocrinology, Diabetes Metabolism

5,958

$488K

468
406 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

7%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

32%
prescriptions for brand name drugs

Avg: 45%

$82
Average prescription price

Avg: $123

JONBEN SVOBODA MD

Endocrinology, Diabetes Metabolism

5,692

$636K

390
238 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

3%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

46%
prescriptions for brand name drugs

Avg: 45%

$112
Average prescription price

Avg: $123

WILLIAM ANDREWS M.D.

Endocrinology, Diabetes Metabolism

5,684

$705K

436
346 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

5%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

40%
prescriptions for brand name drugs

Avg: 45%

$124
Average prescription price

Avg: $123

SHERRY ZHOU MD

Endocrinology, Diabetes Metabolism

5,517

$696K

449
260 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

2%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

42%
prescriptions for brand name drugs

Avg: 45%

$126
Average prescription price

Avg: $123

MUHANNAD AL-KILANI MD

Endocrinology, Diabetes Metabolism

5,500

$532K

341
192 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

0%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

44%
prescriptions for brand name drugs

Avg: 45%

$97
Average prescription price

Avg: $123

MARYANN MUGO MD

Endocrinology, Diabetes Metabolism

5,251

$686K

565
393 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

4%
patients receiving schedule three controlled substances

Avg: 2%

0%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

48%
prescriptions for brand name drugs

Avg: 45%

$131
Average prescription price

Avg: $123

STANLEY MATHEW MD

Endocrinology, Diabetes Metabolism

5,137

$676K

447
338 are 65+

0%
patients receiving schedule two controlled substances

Avg: 0%

2%
patients receiving schedule three controlled substances

Avg: 2%

1%
prescriptions for patients 65+ for potentially dangerous drugs

Avg: 1%

45%
prescriptions for brand name drugs

Avg: 45%

$132
Average prescription price

Avg: $123

Sources

Centers for Medicare and Medicaid Services; National Technical Information Service; First Databank